Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Safety of sugammadex for reversal of neuromuscular block: A postmarketing study based on the World Health Organization pharmacovigilance database.
Br J Clin Pharmacol. 2023 Feb;89(2):449-457. doi: 10.1111/bcp.15417. Epub 2022 Jun 8.
Br J Clin Pharmacol. 2023.
PMID: 35607986
Free article.
AIM: Residual neuromuscular blockade is a common complication after general anaesthesia. Sugammadex can reverse the action of aminosteroid neuromuscular blockers. This study aimed to explore sugammadex safety issues in the real world and determine the spectrum of adverse r …
AIM: Residual neuromuscular blockade is a common complication after general anaesthesia. Sugammadex can reverse the action of aminost …
Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database.
Zheng Y, Guo X, Chen C, Chi L, Guo Z, Liang J, Wei L, Chen X, Ye X, He J.
Zheng Y, et al.
Pharmaceuticals (Basel). 2023 Jan 9;16(1):98. doi: 10.3390/ph16010098.
Pharmaceuticals (Basel). 2023.
PMID: 36678594
Free PMC article.
Item in Clipboard
Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database.
Zheng Y, Guo X, Chen C, Chi L, Guo Z, Liang J, Wei L, Chen X, Ye X, He J.
Zheng Y, et al.
Br J Clin Pharmacol. 2023 Feb;89(2):865-873. doi: 10.1111/bcp.15535. Epub 2022 Oct 7.
Br J Clin Pharmacol. 2023.
PMID: 36106653
Free article.
Item in Clipboard
Cite
Cite